Detalhe da pesquisa
1.
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
; 20(1): 2304974, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512394
2.
Development and clinical validation of Swaasa AI platform for screening and prioritization of pulmonary TB.
Sci Rep
; 13(1): 4740, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959347
3.
Community Dynamics and Engagement Strategies in Establishing Demographic Development and Environmental Surveillance Systems: A Multi-Site Report from India.
Healthcare (Basel)
; 11(3)2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36766985
4.
Screening COVID-19 by Swaasa AI platform using cough sounds: a cross-sectional study.
Sci Rep
; 13(1): 18284, 2023 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880351
5.
Multiple-choice questions in assessment: Perceptions of medical students from low-resource setting.
J Educ Health Promot
; 11: 103, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35573621
6.
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.
EClinicalMedicine
; 42: 101218, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34870133
7.
High Prevalence of CKD of Unknown Etiology in Uddanam, India.
Kidney Int Rep
; 4(3): 380-389, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30899865
8.
Author Correction: Development and clinical validation of Swaasa AI platform for screening and prioritization of pulmonary TB.
Sci Rep
; 13(1): 10353, 2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365280